PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Genetic Epilepsy Program. Neurology Department, Ruber Internacional Hospital, Madrid, Spain. aaledo@neurologiaclinica.es.\', \'Genetic Epilepsy Program. Neurology Department, Ruber Internacional Hospital, Madrid, Spain.\', \'Dravet Syndrome European Federation, Split, Croatia.\', \'Dracaena Consulting, Madrid, Spain.\', \'Vaccines and Advanced Therapies, Spanish Agency of Medicines and Medical Devices, Agencia EspaƱola de Medicamentos Y Productos Sanitarios (AEMPS), Madrid, Spain.\', \'Gene Therapy Program CIMA, IdiSNA, Navarra Institute for Health Research, University of Navarra, Pamplona, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13023-021-01958-3
?:doi
?:hasPublicationType
?:journal
  • Orphanet journal of rare diseases
is ?:pmid of
?:pmid
?:pmid
  • 34271959
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.413
?:rankingScore_hIndex
  • 84
is ?:relation_isRelatedTo_publication of
?:title
  • Gene therapies and COVID-19 vaccines: a necessary discussion in relation with viral vector-based approaches.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all